Arun Iyer

Dr. Arun Iyer is an Associate Professor in the Department of Pharmaceutical Sciences at Wayne State University's Eugene Applebaum College of Pharmacy and Health Sciences. He directs the Use-inspired Biomaterials and Integrated Nano Delivery (U-BiND) Systems Laboratory and serves as a Scientific Member of the Molecular Imaging Program at Karmanos Cancer Institute. His academic credentials include a Ph.D. in Polymer Chemistry/Advanced Drug Delivery Systems from Sojo University (Japan), an M.S. in Polymer Science, and a B.S. in Chemistry from the University of Pune (India), followed by postdoctoral training at UCSF and Northeastern University.

Research Focus

Dr. Iyer's research integrates nanomedicine, biomaterials, and molecular targeting to develop innovative therapeutic strategies. His work focuses on:

• Designing tumor microenvironment-responsive nanoparticles for cancer immunotherapy
• Engineering targeted antibiotic delivery systems to combat superbug infections
• Developing multifunctional nanoplatforms for combined imaging and therapy (theranostics)
• Creating stimuli-responsive nanogels for topical cancer treatment

His lab specializes in polymer chemistry, antibody-drug conjugates, and hypoxia-targeted therapies to overcome drug resistance in aggressive cancers.

Publication Trends

Analysis of Dr. Iyer's recent publications reveals a strong emphasis on nanoscale solutions for oncology and infectious diseases. Key themes include tumor-microenvironment remodeling (particularly hypoxia and stromal targeting), immune checkpoint modulation using antibody-conjugated nanoparticles, and combinatorial approaches against antimicrobial resistance. His work consistently integrates advanced material science with translational objectives, often featuring polymer-lipid hybrid systems and stimuli-responsive designs.

Awards and Honors

• CRS T. Nagai Research Achievement Award (2019)
• DoD Early Career Investigator Award
• Academy of Scholars Junior Faculty Award
• ACS Institutional Research Grant
• Multiple international presentation awards

Research Funding

Dr. Iyer leads several federally funded projects including:

• DoD-CDMRP Idea Development Award ($1.4M) for kidney cancer nanotherapy
• NCI/NIH R21 grant for lung cancer combination therapy
• MTRAC commercialization grant for anti-MRSA nanoparticles
• American Cancer Society IRG for theranostic hybrid nanoparticles

His laboratory collaborates extensively with clinical oncologists and microbiologists to translate nanotechnologies.

Laboratory and Collaborations

The U-BiND Systems Laboratory develops clinically deployable nanoplatforms, with current projects spanning pancreatic cancer immunotherapy, renal carcinoma targeting, and antibiotic reformulation. The team maintains active collaborations with the Karmanos Cancer Institute, UCSF, and Northeastern University, leveraging Wayne State's molecular imaging infrastructure for preclinical validation.